Catalyst Wire Dossier Catalyst Wire Dossier

Normal saline 0.9%

sodium chloride 0.9%
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Normal saline 0.9%, covering 2016-12-06 to 2021-02-18. Get the full timeline:

Most recent: Clinical Trial Update: The Aim of This Study is to Compare the Efficacy of Perioperative Hypertonic Saline 3% Versus Normal Saline (0.9%) in Decreasing Recurrence Risk in Non-muscle Invasive Bladder Cancer [Phase 2]

See pricing